Export

EN
FR
Midazolam
Essential medicine status
Section:
2. Medicines for pain and palliative care 2.3. Medicines for other common symptoms in palliative care
ATC codes: N05CD08
EMLc
Indication
Palliative care ICD11 code: QC7A
INN
Midazolam
Medicine type
Chemical agent
List type
Core (EML)
(EMLc)
Formulations
Oral > Liquid: 2 mg per mL (EMLc)
Parenteral > General injections > unspecified: 1 mg per mL ; 5 mg per mL
Oral > Solid > dosage form: 7.5 mg ; 15 mg
EML status history
First added in 2009 (TRS 958)
Changed in 2013 (TRS 985)
Sex
All
Age
Also recommended for children
Therapeutic alternatives
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Wikipedia
Midazolam
DrugBank
Midazolam
Summary of evidence and Expert Committee recommendations
Following a review of medicines for palliative care by the Expert Committee in 2013, midazolam was added to the EML for use in the management of anxiety, agitation and delerium in patients receiving palliative care. Additional oral dose forms were added to the EMLc.